Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 1
1947 3
1951 5
1953 1
1954 3
1955 4
1957 3
1958 2
1962 2
1963 4
1964 4
1965 1
1972 1
1975 4
1976 5
1977 5
1978 3
1979 10
1980 21
1981 27
1982 46
1983 34
1984 27
1985 37
1986 28
1987 37
1988 42
1989 44
1990 52
1991 60
1992 41
1993 56
1994 53
1995 64
1996 54
1997 97
1998 93
1999 112
2000 151
2001 128
2002 180
2003 219
2004 233
2005 314
2006 393
2007 380
2008 442
2009 500
2010 545
2011 593
2012 646
2013 639
2014 617
2015 573
2016 582
2017 540
2018 498
2019 527
2020 533
2021 449
2022 213
2023 140
2024 115

Text availability

Article attribute

Article type

Publication date

Search Results

9,938 results

Results by year

Filters applied: . Clear all
Page 1
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial.
Erba HP, Montesinos P, Kim HJ, Patkowska E, Vrhovac R, Žák P, Wang PN, Mitov T, Hanyok J, Kamel YM, Rohrbach JEC, Liu L, Benzohra A, Lesegretain A, Cortes J, Perl AE, Sekeres MA, Dombret H, Amadori S, Wang J, Levis MJ, Schlenk RF; QuANTUM-First Study Group. Erba HP, et al. Lancet. 2023 May 13;401(10388):1571-1583. doi: 10.1016/S0140-6736(23)00464-6. Epub 2023 Apr 25. Lancet. 2023. PMID: 37116523 Clinical Trial.
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.
Francque SM, Bedossa P, Ratziu V, Anstee QM, Bugianesi E, Sanyal AJ, Loomba R, Harrison SA, Balabanska R, Mateva L, Lanthier N, Alkhouri N, Moreno C, Schattenberg JM, Stefanova-Petrova D, Vonghia L, Rouzier R, Guillaume M, Hodge A, Romero-Gómez M, Huot-Marchand P, Baudin M, Richard MP, Abitbol JL, Broqua P, Junien JL, Abdelmalek MF; NATIVE Study Group. Francque SM, et al. N Engl J Med. 2021 Oct 21;385(17):1547-1558. doi: 10.1056/NEJMoa2036205. N Engl J Med. 2021. PMID: 34670042 Clinical Trial.
Identification of neural oscillations and epileptiform changes in human brain organoids.
Samarasinghe RA, Miranda OA, Buth JE, Mitchell S, Ferando I, Watanabe M, Allison TF, Kurdian A, Fotion NN, Gandal MJ, Golshani P, Plath K, Lowry WE, Parent JM, Mody I, Novitch BG. Samarasinghe RA, et al. Nat Neurosci. 2021 Oct;24(10):1488-1500. doi: 10.1038/s41593-021-00906-5. Epub 2021 Aug 23. Nat Neurosci. 2021. PMID: 34426698 Free PMC article.
Identification of benzothiazoles as novel PCSK9 inhibitors.
Ma Z, Liu H, Jiang S, Li W, Li Y, Liu Y, Wang L, Li W. Ma Z, et al. Bioorg Med Chem Lett. 2024 Jan 1;97:129542. doi: 10.1016/j.bmcl.2023.129542. Epub 2023 Nov 7. Bioorg Med Chem Lett. 2024. PMID: 37939861
Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH.
Møllerhøj MB, Veidal SS, Thrane KT, Oró D, Overgaard A, Salinas CG, Madsen MR, Pfisterer L, Vyberg M, Simon E, Broermann A, Vrang N, Jelsing J, Feigh M, Hansen HH. Møllerhøj MB, et al. Clin Transl Sci. 2022 May;15(5):1167-1186. doi: 10.1111/cts.13235. Epub 2022 Feb 24. Clin Transl Sci. 2022. PMID: 35143711 Free PMC article.
Newly diagnosed AML: quizartinib improves OS.
Killock D. Killock D. Nat Rev Clin Oncol. 2023 Aug;20(8):504. doi: 10.1038/s41571-023-00787-6. Nat Rev Clin Oncol. 2023. PMID: 37253972 No abstract available.
9,938 results